Journal of Sports Medicine / 2013 / Article / Tab 1

Review Article

A Review of Treatments for Iliotibial Band Syndrome in the Athletic Population

Table 1

Conservative treatment.

StudyNumber of participantsStudy typeTherapeutic regimen (all groups)Group specific therapyComparison between groupsOutcomes, conclusions

Schwellnus et al. [10]43 runnersRCTDay 0–7: rest ice and medication, daily stretching
Days 3, 5, and 7 DTFM
Group 1: placebo
2: anti-inflammatory (Voltaren)
3: anti-inflammatory/analgesic combo (Myprodol)
Group 3 had less pain and increased running time/distance from day 0 to 7All treatments are effective; analgesic/anti-inflammatory is superior

Gunter and Schwellnus [11]18 runnersRCTNo running for 14 days after injection and ice for 30 min every 12 hrs.Group 1: corticosteroid injection (methylprednisolone acetate 40 mg)
Group 2: placebo injection
Using a visual analogue scale for pain perception, significant ( ) decrease in pain during running in group 1 Local corticosteroid infiltration effectively decreases pain during running in the first 2 wks of treatment of ITBS
Group 1 avg. of 53.6% decreases in pain from day 0 to 14

Pinshaw et al. [12]24 runnersCase seriesSofter running shoes, correct leg-length discrepancies, reduce training distance, ice 30 min. BIDResponse to treatment was variable, even some who followed treatment judiciously did not benefitAfter 8 weeks, 44% were 100% cured, 22% were 75% cured, and 34% were 50% or less cured

Fredericson et al. [2]24 (10 M 14 F) injured runners,
30 (16 M 14 F) controls
Case seriesInjured runners enrolled in a 6-week rehab to strengthen gluteus mediusStatistically significant ( ) higher hip abductor torque in control group compared to injured runners.After rehab females increased hip abductor torque 34.9%, males 51.4%22/24 athletes were pain-free and able to return to running, with recurrence at 6 months

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.